Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cortek was a medical device company that specialized in the development and commercialization of structural allograft implants and instrumentation for spinal fusion surgery. The company's product line focused on bone-sparing solutions, utilizing processed human cortical bone to facilitate stable and effective fusion in the cervical and lumbar spine. Its flagship offerings included the Cortek Cortical Bone Dowel and a variety of precision-machined allografts designed to meet the specific anatomical needs of spinal surgeons. In 2005, Cortek was acquired by Alphatec Spine, a subsidiary of Alphatec Holdings, for approximately $10 million plus performance-based milestones. This acquisition allowed Alphatec to expand its presence in the orthopedic and neurosurgical markets by integrating Cortek's specialized bone-grafting technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cortek.